MPO and ganglioneuroma: Nearly one third patients with type I Cr.GN (32%) showing linear staining in immunofluorescence were also positive for ANCAs (anti-MPO 22.5%; anti- PR3 9.7%) making them ‘double positive Cr.GN’.